These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1915825

  • 1. [New drug forms of isosorbide dinitrate: the problem of an objective evaluation in patients with ischemic heart disease].
    Martsevich SIu, Metelitsa VI, Kozyreva MP, Blagodatskikh SV, Simkhaev LS, Piotrovskiĭ VK.
    Farmakol Toksikol; 1991; 54(3):53-6. PubMed ID: 1915825
    [Abstract] [Full Text] [Related]

  • 2. [Dinitrosorbilong--a new Soviet anti-angina preparation. Its comparative pharmacodynamic, pharmacokinetic and clinical study].
    Metelitsa VI, Martsevich SIu, Piotrovskiĭ VK, Blagodatskikh SV, Riabokon' OS.
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):20-4. PubMed ID: 3099808
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of the effects of molsidomine retard and isosorbide dinitrate retard in patients with stable angina pectoris using an ergometry test].
    Rotrekl P, Vlasínová J, Manousek J, Semrád B, Rysavý F, Lupínek Z, Meluzín J, Vlasicová I, Pirochtová I, Bocek O.
    Vnitr Lek; 1993 Sep; 39(9):856-64. PubMed ID: 8212639
    [Abstract] [Full Text] [Related]

  • 4. [Tolerance for the antianginal effect of nitrates. Approaches to its study].
    Martsevich SIu, Shakarova SSh, Metelitsa VI, Strel'tsov AA, Vygodin VA.
    Ter Arkh; 1984 Sep; 56(9):46-50. PubMed ID: 6515547
    [Abstract] [Full Text] [Related]

  • 5. [Isosorbide dinitrate: correlations between its anti-anginal effect, dosage form and administration schedule].
    Martsievich SIu, Metelitsa VI.
    Ter Arkh; 1988 Sep; 60(8):27-30. PubMed ID: 3067408
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Assessment of antianginal efficacy of long-acting sustained release isosorbide dinitrate in comparison with short-acting isosorbide dinitrate.
    Rao YV, Reddy KS, Wasir HS.
    Indian Heart J; 1991 Sep; 43(2):97-100. PubMed ID: 1752623
    [Abstract] [Full Text] [Related]

  • 10. [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
    Kośmicki M, Sadowski Z.
    Przegl Lek; 2000 Sep; 57(9):455-8. PubMed ID: 11199864
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of the antianginal efficacy of sustonit compared with other nitrate drug forms].
    Metelitsa VI, Kokurina EV, Martsevich SIu, Urumbaev RK, Slastnikova ID.
    Ter Arkh; 1989 Sep; 61(8):27-30. PubMed ID: 2511641
    [Abstract] [Full Text] [Related]

  • 12. [Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine].
    Blasini R, Brügmann U, Reiniger G, Rudolph W.
    Herz; 1985 Jun; 10(3):163-71. PubMed ID: 3926613
    [Abstract] [Full Text] [Related]

  • 13. [Orally administered nitroderivates: efficacy and duration of the effects of isosorbide dinitrate (author's transl)].
    De Ponti C, Ciliberto GR.
    G Ital Cardiol; 1976 Jun; 6(6):1008-14. PubMed ID: 798708
    [Abstract] [Full Text] [Related]

  • 14. [Clinico-pharmacological study of a new Russian anti-angina preparation dinitrosorbilong].
    Metelitsa VI, Martsevich SIu, Riabokon' OS, Strel'tsov AA.
    Ter Arkh; 1986 Jun; 58(3):45-9. PubMed ID: 3086997
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of isosorbide dinitrate tape on exercise tolerance of patients with angina pectoris.
    Saito M, Nobuyoshi M, Nakamura N, Nishiyama S, Haze K, Hiramori K, Ikeda M.
    Arzneimittelforschung; 1983 Jun; 33(9):1301-5. PubMed ID: 6685512
    [Abstract] [Full Text] [Related]

  • 16. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M, Szwed H, Kowalik I, Sadowski Z.
    Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
    [Abstract] [Full Text] [Related]

  • 17. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
    Lupanov VP, Alekseeva IA, Vasil'eva NN, Komar OA, Romasiuk SS, Naumov VG.
    Ter Arkh; 2000 Jul; 72(9):33-6. PubMed ID: 11076413
    [Abstract] [Full Text] [Related]

  • 18. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
    Thadani U.
    Z Kardiol; 1985 Jul; 74 Suppl 4():21-4. PubMed ID: 4096067
    [Abstract] [Full Text] [Related]

  • 19. Clinical effects of a sustained-release preparation of isosorbide dinitrate on angina pectoris.
    Arakawa K, Fujino M.
    Clin Ther; 1980 Jul; 3(2):103-16. PubMed ID: 6778614
    [Abstract] [Full Text] [Related]

  • 20. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR, Matheis G, Kleist P, Pötter S, Wohltmann D, Kaltenbach M.
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.